This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting central nervous system disorders, including depression and anxiety, due to its structural similarity to compounds that interact with neurotransmitter systems. Additionally, it is employed in research settings to study receptor binding activities and to develop novel therapeutic agents with improved efficacy and safety profiles. Its chiral nature makes it particularly valuable in the production of enantiomerically pure drugs, ensuring higher specificity and reduced side effects in clinical applications.